Regulatory Roles of Lipopolysaccharide and HMGB1 in Sepsis Pathophysiology
Overview
This review discusses the roles of lipopolysaccharide (LPS) and high mobility group box 1 protein (HMGB1) in the pathophysiology of sepsis, highlighting their interactions.
Background
Sepsis is a severe clinical syndrome with high morbidity and mortality, primarily driven by Gram-negative bacterial infections. Understanding the mechanisms of sepsis is crucial for developing effective therapeutic strategies.
Data Highlights
No numerical data or trial data available in the article.
Key Findings
LPS initiates inflammatory cascades through TLR4 and cytosolic caspases (caspase-11 in mice; caspases-4 and -5 in humans).
The HMGB1–LPS complex is internalized via RAGE-mediated endocytosis, leading to caspase-11 activation.
HMGB1 release amplifies inflammation and coagulopathy, contributing to multi-organ failure in sepsis.
Current therapeutic strategies targeting HMGB1 have shown promise in preclinical models.
TLR4 and caspase pathways may cooperate in a context-dependent manner in human sepsis.
Clinical Implications
Understanding the roles of these molecules could inform the development of treatments for sepsis and related inflammatory disorders.
Conclusion
The review highlights the interplay between LPS and HMGB1 in sepsis pathophysiology.
